Drug reformulations and repositioning in pharmaceutical industry and its impact on market access: reassessment of nomenclature

BACKGROUND: Medicinal products that have been developed and approved for one disease may be the object of additional clinical development in other disease areas or of additional pharmaceutical development for new and different formulations. The newly developed products can be named as repositioned o...

Descripción completa

Detalles Bibliográficos
Autores principales: Murteira, Susana, Ghezaiel, Zied, Karray, Slim, Lamure, Michel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Co-Action Publishing 2013
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4865745/
https://www.ncbi.nlm.nih.gov/pubmed/27226826
http://dx.doi.org/10.3402/jmahp.v1i0.21131

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4865745/
https://www.ncbi.nlm.nih.gov/pubmed/27226826
http://dx.doi.org/10.3402/jmahp.v1i0.21131

Ejemplares similares